Lv4
476 积分 2022-10-31 加入
Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli
13小时前
已完结
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
4天前
已完结
Biosynthesis, Chemical Synthesis, and Pharmacological Evaluation of Lyngbyapeptin A as a GPCR Antagonist of Motilin, Cannabinoid, and Amylin Receptors
6天前
已完结
β-Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
6天前
已完结
Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides
14天前
已完结
Engineering of an Ultralong-Acting and Nonaggregating Dual Amylin and Calcitonin Receptor Agonist with Durable Efficacy in Obesity and Diabetes
18天前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
28天前
已完结
Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study
28天前
已关闭
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
28天前
已完结
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
1个月前
已完结
皖公网安备34019202002308
